Tradition Wealth Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$387K Sell
6,939
-15
-0.2% -$812 0.02% 367
2026
Q2
$382K Buy
6,954
+273
+4% +$11.2K 0.02% 362
2026
Q1
$222K Buy
+6,681
New +$199K 0.02% 454
2025
Q4
– Sell
-6,066
Closed -$219K – 513
2025
Q3
$219K Buy
6,066
+360
+6% +$11.9K 0.02% 441
2025
Q2
$205K Sell
5,706
-252
-4% -$9.38K 0.02% 424
2025
Q1
$235K Buy
+5,958
New +$200K 0.02% 386
2024
Q1
– Sell
-5,958
Closed -$102K – 1106
2023
Q4
$102K Hold
5,958
– – 0.01% 469
2023
Q3
$50K Hold
5,958
– – 0.01% 606
2023
Q2
$148K Sell
5,958
-2,285
-28% -$59K 0.02% 364
2023
Q1
$124K Buy
8,243
+1,785
+28% +$27.1K 0.02% 387
2022
Q4
$76K Hold
6,458
– – 0.01% 436
2022
Q3
$38K Hold
6,458
– – 0.01% 591
2022
Q2
$27K Sell
6,458
-439
-6% -$2.74K ﹤0.01% 593
2022
Q1
$66K Buy
6,897
+821
+14% +$9.5K 0.01% 452
2021
Q4
$115K Buy
6,076
+1,130
+23% +$29.3K 0.01% 380
2021
Q3
$165K Buy
4,946
+410
+9% +$12.7K 0.02% 299
2021
Q2
$176K Hold
4,536
– – 0.03% 304
2021
Q1
$219K Hold
4,536
– – 0.04% 240
2020
Q4
$236K Buy
+4,536
New +$153K 0.05% 215

Other funds holding TGTX

Tradition Wealth Management's TGTX Position: Q3 2026 in Review

Tradition Wealth Management reduced its TG Therapeutics (TGTX) stake by 0.22% in Q3 2026, selling an estimated $812 and leaving 6,939 shares worth $387K. The position accounts for 0.02% of the portfolio, ranked #367.

Tradition Wealth Management first reported a position in TGTX in Q4 2020 and has held it in 19 quarters since. 361 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Tradition Wealth Management held 6,939 shares of TG Therapeutics worth $387K as of Q3 2026.
  • Tradition Wealth Management sold 15 TG Therapeutics shares in Q3 2026, an estimated $812.
  • TG Therapeutics made up 0.02% of Tradition Wealth Management's portfolio in Q3 2026, its #367 holding.
  • Tradition Wealth Management first reported a position in TG Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • 361 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Tradition Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.